a public good project by the
Synthesis
Company
of California

© 2026

Ae‐Ran Choi | doi.page

0 works0 citations0 h-index

Ae‐Ran Choi

Ulsan College(KR)Asan Medical Center(KR)University of Ulsan(KR)

Publications by Year

Research Areas

Drug Transport and Resistance Mechanisms, SARS-CoV-2 and COVID-19 Research, Renal Transplantation Outcomes and Treatments, Cytomegalovirus and herpesvirus research, Cancer therapeutics and mechanisms

Most-Cited Works

→ Comparison of Six Commercial Diagnostic Tests for the Detection of Dengue Virus Non-Structural-1 Antigen and IgM/IgG Antibodies(2019)65 cited
→ Natural killer cell activity for IFN-gamma production as a supportive diagnostic marker for gastric cancer(2017)58 cited
→ Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients(2017)56 cited
→ Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays(2021)41 cited
Anti-malarial Drugs Primaquine and Chloroquine Have Different Sensitization Effects with Anti-mitotic Drugs in Resistant Cancer Cells.(2016)
→ Quantitative SARS-CoV-2 Spike Antibody Response in COVID-19 Patients Using Three Fully Automated Immunoassays and a Surrogate Virus Neutralization Test(2021)39 cited
→

Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition

(2013)

38 cited

→ Attenuation of Colchicine Toxicity in Drug-resistant Cancer Cells by Co-treatment with Anti-malarial Drugs(2016)36 cited

→ Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients(2018)34 cited

→ Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C(2018)32 cited